| 000 | 01775 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250514155232.0 | ||
| 264 | 0 | _c20040528 | |
| 008 | 200405s 0 0 eng d | ||
| 022 | _a1078-0432 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWolff, Antonio C | |
| 245 | 0 | 0 |
_aPhase I study of docosahexaenoic acid-paclitaxel: a taxane-fatty acid conjugate with a unique pharmacology and toxicity profile. _h[electronic resource] |
| 260 |
_bClinical cancer research : an official journal of the American Association for Cancer Research _cSep 2003 |
||
| 300 |
_a3589-97 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 | _aArea Under Curve |
| 650 | 0 | 4 |
_aDocosahexaenoic Acids _xadministration & dosage |
| 650 | 0 | 4 |
_aFatty Acids _xchemistry |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aModels, Chemical |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aPaclitaxel _xadministration & dosage |
| 650 | 0 | 4 |
_aTaxoids _xtherapeutic use |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aDonehower, Ross C | |
| 700 | 1 | _aCarducci, M Katherine | |
| 700 | 1 | _aCarducci, Michael A | |
| 700 | 1 | _aBrahmer, Julie R | |
| 700 | 1 | _aZabelina, Yelena | |
| 700 | 1 | _aBradley, Matthews O | |
| 700 | 1 | _aAnthony, Forrest H | |
| 700 | 1 | _aSwindell, Charles S | |
| 700 | 1 | _aWitman, Philip A | |
| 700 | 1 | _aWebb, Nigel L | |
| 700 | 1 | _aBaker, Sharyn D | |
| 773 | 0 |
_tClinical cancer research : an official journal of the American Association for Cancer Research _gvol. 9 _gno. 10 Pt 1 _gp. 3589-97 |
|
| 999 |
_c14267202 _d14267202 |
||